학술논문
Transcatheter Closure in Symptomatic Neonates and Young Infants with Patent Ductus Arteriosus / 新生児・乳児早期の症候性動脈管開存症に対するカテーテル治療の有効性と安全性
Document Type
Journal Article
Author
Chie Yokota; Daisuke Shimizu; Hiroki Ezaki; Hiroto Doi; Jun Muneuchi; Junko Yamamoto; Junya Ohmura; Kenichiro Yamaguchi; Mamie Watanabe; Naoki Kawaguchi; Ryohei Matsuoka; Takuro Ohno; Yasuhiko Takahashi; Yoshie Ochiai; Yuichiro Sugitani; 土井 大人; 大村 隼也; 大野 拓郎; 宗内 淳; 山口 賢一郎; 山本 順子; 川口 直樹; 杉谷 雄一郎; 松岡 良平; 横田 千恵; 江崎 大起; 清水 大輔; 渡邉 まみ江; 落合 由恵; 高橋 保彦
Source
日本小児循環器学会雑誌 / Pediatric Cardiology and Cardiac Surgery. 2020, 36(2):133
Subject
Language
Japanese
ISSN
0911-1794
2187-2988
2187-2988
Abstract
Results: Age (115 days, range 6–212) and weight (4.20 kg, 1.62–8.79) at procedure, pulmonary to systemic flow ratio (3.54, 1.06–8.08), mean pulmonary arterial pressure (28 mmHg, 12–60), and ductal diameter (4.3 mm, 1.1–8.8) did not significantly differ between the groups. Within the transcatheter closure group, we used Amplatzer™ Duct Occluder (ADO) in 8, ADO-II in 1, and Amplatzer™ Vascular Plug-II (AVP-II) in 6 patients. Complete occlusions were attained in all but 2 patients, following successful surgical closure. There were 4 major adverse events in the transcatheter closure group (1 device migration, 2 transfusions, 1 pneumonia) and 3 major adverse events in the surgical closure group (1 chylothorax, 1 respiratory failure, 1 coarctation), which did not differ between the groups. There were no deaths related to either procedure.